[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Insulin (API & Injection) Market Professional Survey Report 2016

June 2016 | 105 pages | ID: G80B7260E26EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report mainly covers the following

Product types including
  • Animal Insulin
  • Human Insulin
  • Insulin Analogue
The segment applications including
  • Short acting
  • Interme diate acting insulin
  • Long acting insulin
  • Pre-mix Insulin
Segment regions including (the separated region report can also be offered)
  • EU
  • USA
  • India
  • Japan
  • China
The players list (Partly, Players you are interested in can also be added)
  • Novo Nordisk
  • Eli Lilly
  • Sanofi-Aventis
  • Dongbao
  • Bioton
  • United Laboratories
  • Merck
  • Ganlee
  • .
With no less than 10 top producers.

Data including (both global and regions): Market Size (both volume - L and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/ml, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 INDUSTRY OVERVIEW OF INSULIN (API & INJECTION)

1.1 Definition and Specifications of Insulin (API & Injection)
  1.1.1 Definition of Insulin (API & Injection)
  1.1.2 Specifications of Insulin (API & Injection)
1.2 Classification of Insulin (API & Injection)
  1.2.1 Animal Insulin
  1.2.2 Human Insulin
  1.2.3 Insulin Analogue
1.3 Applications of Insulin (API & Injection)
  1.3.1 Short acting
  1.3.2 Interme diate acting insulin
  1.3.3 Long acting insulin
  1.3.4 Pre-mix Insulin
1.4 Industry Chain Structure of Insulin (API & Injection)
1.5 Industry Overview and Major Regions Status of Insulin (API & Injection)
  1.5.1 Industry Overview of Insulin (API & Injection)
  1.5.2 Global Major Regions Status of Insulin (API & Injection)
1.6 Industry Policy Analysis of Insulin (API & Injection)
1.7 Industry News Analysis of Insulin (API & Injection)

2 MANUFACTURING COST STRUCTURE ANALYSIS OF INSULIN (API & INJECTION)

2.1 Raw Material Suppliers and Price Analysis of Insulin (API & Injection)
2.2 Equipment Suppliers and Price Analysis of Insulin (API & Injection)
2.3 Labor Cost Analysis of Insulin (API & Injection)
2.4 Other Costs Analysis of Insulin (API & Injection)
2.5 Manufacturing Cost Structure Analysis of Insulin (API & Injection)
2.6 Manufacturing Process Analysis of Insulin (API & Injection)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF INSULIN (API & INJECTION)

3.1 Capacity and Commercial Production Date of Global Insulin (API & Injection) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Insulin (API & Injection) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Insulin (API & Injection) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Insulin (API & Injection) Major Manufacturers in 2015

4 GLOBAL INSULIN (API & INJECTION) OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Insulin (API & Injection) Capacity and Growth Rate Analysis
  4.2.2 2015 Insulin (API & Injection) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Insulin (API & Injection) Sales and Growth Rate Analysis
  4.3.2 2015 Insulin (API & Injection) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Insulin (API & Injection) Sales Price
  4.4.2 2015 Insulin (API & Injection) Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Insulin (API & Injection) Gross Margin
  4.5.2 2015 Insulin (API & Injection) Gross Margin Analysis (Company Segment)

5 INSULIN (API & INJECTION) REGIONAL MARKET ANALYSIS

5.1 EU Insulin (API & Injection) Market Analysis
  5.1.1 EU Insulin (API & Injection) Market Overview
  5.1.2 EU 2011-2016E Insulin (API & Injection) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 EU 2011-2016E Insulin (API & Injection) Sales Price Analysis
  5.1.4 EU 2015 Insulin (API & Injection) Market Share Analysis
5.2 USA Insulin (API & Injection) Market Analysis
  5.2.1 USA Insulin (API & Injection) Market Overview
  5.2.2 USA 2011-2016E Insulin (API & Injection) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 USA 2011-2016E Insulin (API & Injection) Sales Price Analysis
  5.2.4 USA 2015 Insulin (API & Injection) Market Share Analysis
5.3 India Insulin (API & Injection) Market Analysis
  5.3.1 India Insulin (API & Injection) Market Overview
  5.3.2 India 2011-2016E Insulin (API & Injection) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 India 2011-2016E Insulin (API & Injection) Sales Price Analysis
  5.3.4 India 2015 Insulin (API & Injection) Market Share Analysis
5.4 Japan Insulin (API & Injection) Market Analysis
  5.4.1 Japan Insulin (API & Injection) Market Overview
  5.4.2 Japan 2011-2016E Insulin (API & Injection) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2011-2016E Insulin (API & Injection) Sales Price Analysis
  5.4.4 Japan 2015 Insulin (API & Injection) Market Share Analysis
5.5 China Insulin (API & Injection) Market Analysis
  5.5.1 China Insulin (API & Injection) Market Overview
  5.5.2 China 2011-2016E Insulin (API & Injection) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 China 2011-2016E Insulin (API & Injection) Sales Price Analysis
  5.5.4 China 2015 Insulin (API & Injection) Market Share Analysis

6 GLOBAL 2011-2016E INSULIN (API & INJECTION) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Insulin (API & Injection) Sales by Type
6.2 Different Types Insulin (API & Injection) Product Interview Price Analysis
6.3 Different Types Insulin (API & Injection) Product Driving Factors Analysis
  6.3.1 Animal Insulin Insulin (API & Injection) Growth Driving Factor Analysis
  6.3.2 Human Insulin Insulin (API & Injection) Growth Driving Factor Analysis
  6.3.3 Insulin Analogue Insulin (API & Injection) Growth Driving Factor Analysis

7 GLOBAL 2011-2016E INSULIN (API & INJECTION) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Short acting Insulin (API & Injection) Growth Driving Factor Analysis
  7.3.2 Interme diate acting insulin Insulin (API & Injection) Growth Driving Factor Analysis
  7.3.3 Long acting insulin Insulin (API & Injection) Growth Driving Factor Analysis
  7.3.4 Pre-mix Insulin Insulin (API & Injection) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF INSULIN (API & INJECTION)

8.1 Novo Nordisk
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Novo Nordisk 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novo Nordisk 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.2 Eli Lilly
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Eli Lilly 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eli Lilly 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.3 Sanofi-Aventis
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Sanofi-Aventis 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi-Aventis 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.4 Dongbao
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Dongbao 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Dongbao 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.5 Bioton
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Bioton 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Bioton 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.6 United Laboratories
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 United Laboratories 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 United Laboratories 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.7 Merck
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Merck 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Merck 2015 Insulin (API & Injection) Business Region Distribution Analysis
8.8 Ganlee
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Ganlee 2015 Insulin (API & Injection) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Ganlee 2015 Insulin (API & Injection) Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 EU 2016-2021 Insulin (API & Injection) Consumption Forecast
  9.2.2 USA 2016-2021 Insulin (API & Injection) Consumption Forecast
  9.2.3 India 2016-2021 Insulin (API & Injection) Consumption Forecast
  9.2.4 Japan 2016-2021 Insulin (API & Injection) Consumption Forecast
  9.2.5 China 2016-2021 Insulin (API & Injection) Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 INSULIN (API & INJECTION) MARKETING MODEL ANALYSIS

10.1 Insulin (API & Injection) Regional Marketing Model Analysis
10.2 Insulin (API & Injection) International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Insulin (API & Injection) by Regions
10.4 Insulin (API & Injection) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF INSULIN (API & INJECTION)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF INSULIN (API & INJECTION)

12.1 New Project SWOT Analysis of Insulin (API & Injection)
12.2 New Project Investment Feasibility Analysis of Insulin (API & Injection)

13 CONCLUSION OF THE GLOBAL INSULIN (API & INJECTION) MARKET PROFESSIONAL SURVEY REPORT 2016


More Publications